These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 35073787)
81. Involvement of Cholinergic, Adrenergic, and Glutamatergic Network Modulation with Cognitive Dysfunction in Alzheimer's Disease. Cheng YJ; Lin CH; Lane HY Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668976 [TBL] [Abstract][Full Text] [Related]
82. Amyloid beta peptides and glutamatergic synaptic dysregulation. Parameshwaran K; Dhanasekaran M; Suppiramaniam V Exp Neurol; 2008 Mar; 210(1):7-13. PubMed ID: 18053990 [TBL] [Abstract][Full Text] [Related]
83. APOE-Sensitive Cholinergic Sprouting Compensates for Hippocampal Dysfunctions Due to Reduced Entorhinal Input. Bott JB; Héraud C; Cosquer B; Herbeaux K; Aubert J; Sartori M; Goutagny R; Mathis C J Neurosci; 2016 Oct; 36(40):10472-10486. PubMed ID: 27707979 [TBL] [Abstract][Full Text] [Related]
99. Reduction of synaptojanin 1 ameliorates synaptic and behavioral impairments in a mouse model of Alzheimer's disease. McIntire LB; Berman DE; Myaeng J; Staniszewski A; Arancio O; Di Paolo G; Kim TW J Neurosci; 2012 Oct; 32(44):15271-6. PubMed ID: 23115165 [TBL] [Abstract][Full Text] [Related]